NTxBio
PrivateLast Round
Grant
May 14, 2025
Total Funding Raised
$75.84M
Company Overview
NTx is a biotechnology company that provides a bioinformatics and biomanufacturing platform for the identification, evaluation, and prioritization of natural drug discovery targets through high-throughput screening and real-time metabolic profiling of various organisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NTxBio Comps
Public and private peers based on sector, stage, and business model.
NTxBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2025 | ||||
| Debt | Dec 4, 2024 | ||||
| Series B | Nov 16, 2023 | ||||
| Grant | Feb 25, 2020 | ||||
| Series A | Feb 25, 2020 |
Key People
Founding team and executive leadership
NTxBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A, Series B |
| Texas Enterprise Fund | Grant |
| Anzu Partners | Series B, Series A |
| New Mexico Economic Development Department | Grant |
| BlueStone Venture Partners | Series B |
| J.P. Morgan | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
Opening a new $31 million facility and adding 170 jobs in Texas.
- Mar 4, 2025
Joan Haab, Ph.D. appointed as Chief Operations Officer.
NTxBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NTxBio's valuation, stock price, and market status.
